Mode of action of fibrates

This publication has 46 references indexed in Scilit:

• REGRESSION OF COMPUTER ESTIMATED FEMORAL ATHEROSCLEROSIS AFTER PRONOUNCED SERUM LIPID LOWERING IN PATIENTS WITH ASYMPTOMATIC HYPERLIPIDAEMIA
  The Lancet, 1982
• Gemfibrozil in the Treatment of Dyslipidaemias in Middle‐Aged Male Survivors of Myocardial Infarction
  Acta Medica Scandinavica, 1981
• Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations
  Atherosclerosis, 1980
• Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters
  Atherosclerosis, 1980
• Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis
  New England Journal of Medicine, 1979
• Atherogenesis: a postprandial phenomenon.
  Circulation, 1979
• Increase of the lipoprotein‐lipase activity in human skeletal muscle during clof ibrate administration
  European Journal of Clinical Investigation, 1978
• Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia Effect of 2,2-dimethyl, 5(2,5-xylyloxy) valeric acid therapy
  Atherosclerosis, 1976
• Effects of clofibrate on sterol metabolism in the rat
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1974
• The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V Hypertriglyceridaemia
  European Journal of Clinical Investigation, 1974